ALBATROSS with GLPG2222 shows positive clinical results in CF patients

Evaluation of C1 corrector GLPG2222 on top of ivacaftor (Kalydeco®[1]) in heterozygous Class III/F508del CFTR patients Patient study recruited within 5 months in Europe and Australia GLPG2222 was well tolerated dosed once daily for 28 days Dose dependent increase in FEV1 Statistically significant dose dependent decreases in sweat chloride Further clinical validation of … [Read more...]

Veritas Pharma Enters Binding Letter of Intent to Secure ACMPR License and Cannabis Growing Facility

VANCOUVER, British Columbia, Nov. 18, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”), an emerging-stage pharmaceutical and IP development company, is pleased to announce that it has signed a Binding Letter of Intent with 906474 Alberta Ltd. (“906474”) subject to regulatory authority to acquire 100% ownership of … [Read more...]

NOVAN SHAREHOLDER ALERT: CLAIMSFILER REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Novan, Inc. – (NOVN)

NEW ORLEANS, Nov. 17, 2017 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 2, 2018 to file lead plaintiff applications in a securities class action lawsuit against Novan, Inc. (Nasdaq:NOVN), if they purchased the Company’s shares between September 26, 2016 and January 26, 2017 (the “Class Period”) and/or … [Read more...]

FalconStor Software Secures Financing Commitment From Hale Capital

MELVILLE, N.Y., Nov. 17, 2017 (GLOBE NEWSWIRE) -- FalconStor Software, Inc. (OTCMKTS:FALC) (“FalconStor” or the “Company”), today announced that the Company has secured a commitment (the “Commitment”) from HCP-FVA, LLC, an affiliate of Hale Capital Partners, LP (together, “Hale Capital”), to purchase up to $3 million worth of units from the Company in a proposed private … [Read more...]

LogMeIn Announces 2017 Investor Day

BOSTON, Nov. 17, 2017 (GLOBE NEWSWIRE) -- LogMeIn, Inc. (NASDAQ:LOGM), a leading provider of cloud-based connectivity, is pleased to announce its first Investor Day on Tuesday, December 19th, 2017, from 7:30 a.m. to 12:00 p.m. The event will be held in Boston at the Aloft Seaport Hotel on 401 D Street. To register, please contact LogMeIn Investor Relations at … [Read more...]